SpringWorks
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SpringWorks and buy or sell other stocks, ETFs, and their options commission-free!About SWTX
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor.
CEOSaqib Islam
CEOSaqib Islam
Employees368
Employees368
HeadquartersStamford, Connecticut
HeadquartersStamford, Connecticut
Founded2017
Founded2017
Employees368
Employees368
SWTX Key Statistics
Market cap3.52B
Market cap3.52B
Price-Earnings ratio-13.78
Price-Earnings ratio-13.78
Dividend yield—
Dividend yield—
Average volume1.47M
Average volume1.47M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$62.00
52 Week high$62.00
52 Week low$28.21
52 Week low$28.21
Stock Snapshot
With a market cap of 3.52B, SpringWorks(SWTX) trades at $46.99. The stock has a price-to-earnings ratio of -13.78.
SpringWorks(SWTX) stock opened on 2025-12-04 at —. The price climbed to — and dipped to —.
SpringWorks(SWTX) shares are trading with a volume of 0, against a daily average of 1.47M.
In the last year, SpringWorks(SWTX) shares hit a 52-week high of $62.00 and a 52-week low of $28.21.
In the last year, SpringWorks(SWTX) shares hit a 52-week high of $62.00 and a 52-week low of $28.21.
People also own
Based on the portfolios of people who own SWTX. This list is generated using Robinhood data, and it’s not a recommendation.